Purchases and Sales Made in Q3 2024 in Vir Biotechnology, Inc. (VIR)
This table provides information about the institutional ownership of Vir Biotechnology, Inc. (VIR) during Q3 2024. The information is specifically focused on institutions that hold shares of Vir Biotechnology, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2024
Q3 2024
|
Jump Financial, LLC
Chicago, IL |
SELL
|
- |
-82.8K- 71.59% |
$601K - $886K
|
32.9K
$243K
|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-143K- 11.49% |
$1.04M - $1.53M
|
1.1M
$8.17M
|
|
Nov 13, 2024
Q3 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-147K- 11.09% |
$1.07M - $1.58M
|
1.18M
$8.75M
|
|
Nov 06, 2024
Q3 2024
|
Empowered Funds, LLC
|
SELL
|
- |
-164K- 33.18% |
$1.19M - $1.75M
|
330K
$2.44M
|
|
Dec 26, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-169K- 13.46% |
$1.23M - $1.81M
|
1.09M
$8.04M
|
|
Nov 08, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-169K- 13.46% |
$1.23M - $1.81M
|
1.09M
$8.04M
|
|
Nov 14, 2024
Q3 2024
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-223K- 81.04% |
$1.62M - $2.39M
|
52.3K
$387K
|
|
Nov 13, 2024
Q3 2024
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-249K- 82.92% |
$1.81M - $2.66M
|
51.3K
$379K
|
|
Nov 14, 2024
Q3 2024
|
Voloridge Investment Management, LLC
Jupiter, FL |
SELL
|
- |
-250K- 20.38% |
$1.81M - $2.67M
|
975K
$7.22M
|
|
Nov 14, 2024
Q3 2024
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-459K- 58.19% |
$3.33M - $4.91M
|
330K
$2.44M
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-481K- 64.14% |
$3.49M - $5.15M
|
269K
$1.99M
|
|
Nov 14, 2024
Q3 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-515K- 60.48% |
$3.74M - $5.51M
|
337K
$2.49M
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-886K- 41.74% |
$6.43M - $9.48M
|
1.24M
$9.15M
|
|
Nov 05, 2024
Q3 2024
|
Baillie Gifford & CO
|
SELL
|
- |
-1.54M- 39.23% |
$11.2M - $16.5M
|
2.38M
$17.6M
|